Lipid management in the proteinuric patient: do not overlook the importance of proteinuria reduction.
Vogt
Liffert
L
Department of internal Medicine, Division of Nephrology, University Medical Center Groningen, Hanzeplein 1, 9713 GX Groningen, The Netherlands. l.vogt@int.azg.nl
Laverman
Gozewijn D
GD
Dullaart
Robin P F
RP
Navis
Gerjan
G
D002318:Cardiovascular Diseases / Q000150:complications; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D006949:Hyperlipidemias / Q000150:complications / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008074:Lipoproteins / Q000097:blood; D011507:Proteinuria / Q000150:complications / Q000188:drug therapy*; D012306:Risk
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D008074:Lipoproteins